Moderna MRNA
NASDAQ MRNA
$254.19 +12.73 (+5.27%)
At close: Nov 6, 2026 · 4:00 PM EST

Moderna (MRNA) Invested Capital (2024 - 2026)

Updated

Moderna's Invested Capital came in at $7.35 billion for Q2 2026, down 8.1% from the prior quarter.

Analysis

Moderna (MRNA) Invested Capital (2024 - 2026) Analysis & Trends

For FY2025, Moderna's Invested Capital was $9.24 billion, down 15.2% from FY2024.

  • Going back by year, Invested Capital was $10.9 billion in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 126.18 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 76.32 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 39.85 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 151.97 Bn
10 Moderna 100.92 Bn 80.27 Bn 52.00 Mn 7.35 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.35 Bn
Mar 31, 2026 8.00 Bn
Dec 31, 2025 9.24 Bn
Dec 31, 2024 10.90 Bn
API Access

Moderna Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=MRNA&period=max&api_key=YOUR_API_KEY